LambdaVision has recently closed a $7M seed funding round co-led by Seven Seven Six and Aurelia Foundry Fund, with additional support from Seraphim Space, providing runway into 2027. With this funding ...
Opus Genetics targets inherited retinal diseases with one-dose AAV gene augmentations. Read why IRD stock is a Buy.
Blurry vision isn’t always due to screen strain or ageing. Ophthalmologists warn it can signal vitamin deficiencies like A, ...
Paired with external glasses, a tiny chip that is surgically placed under the retina is helping people who are legally blind ...
Researchers from Harvard Medical School and Spark Therapeutics Inc. tested subretinal NRF2 gene therapy in dry AMD models to investigate whether it could relieve oxidative stress and inflammation.
Company will debut five-year results from GALE study showing meaningful impact of early and continuous treatment with SYFOVRE® (pegcetacoplan ...
Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography-based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results